Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis
about
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated formFlow cytometry as a diagnostic tool in the early diagnosis of aggressive lymphomas mimicking life-threatening infection.The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells.IL-2 mRNA expression in Tac-positive malignant lymphomasMalignant histiocytosis. A phenotypic and genotypic investigation.Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.High expression of the CD30 molecule in human decidual cellsALK-immunoreactive neoplasms.Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin.Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study GroupPathobiology of ALK-negative anaplastic large cell lymphoma.Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.Pathobiology of anaplastic large cell lymphoma.Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).Clinical characteristics and treatment outcomes of children with anaplastic large cell lymphoma: a single center experience.Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas.Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumorsDiagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells.Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.
P2860
Q28365593-068A6E74-7912-4C71-90B3-F44CA534E9E0Q35043982-D6410E1D-3F23-4450-9776-8DB9C314D489Q35763911-E227572A-7625-41C7-B8CE-62F4F8E6255DQ35764876-CB04715F-F176-4F4F-979A-7F89478DFB91Q35811193-1D568167-1ADE-46CC-84D0-1D047C52039CQ35811272-91DD8EFF-2E13-4D80-B407-0BDBDD863BE3Q35812018-271B0D6C-9AD2-4D7E-A37C-324148381237Q35833942-55484C01-7842-48DB-923D-EA65EE6B484EQ36092957-63B9B7B3-19E6-4DB8-8E9D-741B76605EEFQ37144842-0BDA9C0D-0E66-4910-AA59-B51F505FC35CQ37202621-F5B4A65B-FD95-420C-B921-4D39FCDB2C6FQ38912284-3590EE5D-5698-4DCA-9B0F-6467AEA5D2CDQ40020875-A564A287-370B-493B-9D8D-2B114715F22DQ41852473-65670E12-402F-4444-A7C0-DDBA178C892EQ42065454-A1B4189F-003C-4809-AEC3-7BB61396B28DQ42086879-E5F0F198-31B7-456A-82D2-CE451CA52F90Q42755811-7D663D78-0EA8-48DB-A230-62A1F2B301A1Q42756278-EECE8DE3-80EB-44A7-A065-B7BCFDEFB03FQ42768028-BE4B180D-DBD5-4803-9290-7DEFA8CFF872Q42774342-490C1305-F92B-4292-B968-E0B172295482Q52619047-E9F84075-9AF8-40EC-9280-7D42160825DB
P2860
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Coexpression of epithelial mem ...... called malignant histiocytosis
@ast
Coexpression of epithelial mem ...... called malignant histiocytosis
@en
type
label
Coexpression of epithelial mem ...... called malignant histiocytosis
@ast
Coexpression of epithelial mem ...... called malignant histiocytosis
@en
prefLabel
Coexpression of epithelial mem ...... called malignant histiocytosis
@ast
Coexpression of epithelial mem ...... called malignant histiocytosis
@en
P2093
P2860
P1476
Coexpression of epithelial mem ...... called malignant histiocytosis
@en
P2093
F Rigal-Huguet
K C Gatter
P Caveriviere
R Schwarting
T Al Saati
P2860
P407
P577
1988-01-01T00:00:00Z